Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom.
College of Medicine, University of Lagos, Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria; Lagos University Teaching Hospital, Idi-araba, Lagos State, Nigeria.
Parkinsonism Relat Disord. 2023 Aug;113:105517. doi: 10.1016/j.parkreldis.2023.105517. Epub 2023 Jul 14.
The association between MAPT and PD risk may be subject to ethnic variability even within populations of similar geographical origin. Data on MAPT haplotype frequencies, and its association with PD risk in black Africans are lacking. We aimed to determine the frequencies of MAPT haplotypes and their role as risk factors for PD and age at onset in Nigerians.
The haplotype and genotype frequencies of MAPT rs1052553 were analysed in 907 individuals with PD and 1022 age-matched healthy controls from the Nigeria Parkinson's Disease Research network cohort. Clinical data related to PD included age at study, age at onset (AAO), and disease duration.
The frequency of the H1 haplotype was 98.7% in PD, and 99.1% in controls (p = 0.19). The H2 haplotype was present in - 1.3% of PD and 0.9% of controls (p = 0.24). The most frequent MAPT genotype was H1H1 (PD - 97.5%, controls - 98.2%). The H1 haplotype was not associated with PD risk after accounting for gender and AAO (Odds ratio for H1/H1 vs H1/H2 and H2/H2: 0.68 (95% CI:0.39-1.28); p = 0.23).
Our findings support previous studies that report a low frequency of the MAPT H2 haplotype in black ancestry Africans but document its occurrence in Nigerians. The MAPT H1 haplotype was not associated with an increased risk or age at onset of PD in this cohort.
即使在具有相似地理起源的人群中,MAPT 与 PD 风险的关联也可能受到种族变异性的影响。关于 MAPT 单倍型频率的数据及其与黑非洲人 PD 风险的关联尚不清楚。我们旨在确定 MAPT 单倍型的频率及其作为 PD 风险因素和尼日利亚人发病年龄的作用。
分析了来自尼日利亚帕金森氏病研究网络队列的 907 名 PD 患者和 1022 名年龄匹配的健康对照者中 MAPT rs1052553 的单倍型和基因型频率。与 PD 相关的临床数据包括研究时的年龄、发病年龄(AAO)和疾病持续时间。
PD 中 H1 单倍型的频率为 98.7%,对照组为 99.1%(p=0.19)。H2 单倍型在 PD 中为 -1.3%,对照组为 0.9%(p=0.24)。最常见的 MAPT 基因型是 H1H1(PD-97.5%,对照组-98.2%)。在考虑性别和 AAO 后,H1 单倍型与 PD 风险无关(H1/H1 与 H1/H2 和 H2/H2 的比值比:0.68(95%CI:0.39-1.28);p=0.23)。
我们的研究结果支持先前的研究报告,即黑种人后裔中 MAPT H2 单倍型的频率较低,但证明其在尼日利亚人中存在。在该队列中,MAPT H1 单倍型与 PD 风险或发病年龄无关。